Insights On Partnering

  1. Agility And Expertise Combine To Overcome Late Stage Design Issues In Comparator Study 11/22/2019

    Encountering unforeseen problems when sourcing a comparator for an investigational product can severely impact the success of a clinical trial. Download this case study to learn how Almac Clinical Services helped one sponsor overcome late stage design issues through successful sourcing and procurement of a suitable alternative comparator.

  2. Rapid Change, Real Promise: The Future Of Rare Oncology Research 12/26/2018

    Insight on the major issues being raised in the rare oncology space today, including patient perspectives on rare cancer research, innovative trial designs, the regulatory landscape, and pending legislation that may impact how studies are conducted.

  3. Protecting The Integrity Of Your Temperature Data In A Digital World 2/26/2019

    Watch Almac’s on-demand webinar to gain an understanding of data integrity regulations and key considerations when utilizing a computerized system to manage temperature data during clinical trials.  This webinar will demonstrate how a secure, validated system is key in ensuring effective collection and management of accurate temperature data from the entire clinical supply chain.  

  4. Investigator Retention Pro Tip: Speed Clinical Trial Payments 2/26/2020

    If you have to pay clinical research sites for conducting clinical trials, then you know the importance of on-time payments to retain good investigators for future studies. Discover a new way to speed payments and increase visibilty with Vault CTMS.

  5. Considerations When Implementing New Technology At Clinical Trial Sites 3/3/2020

    More than 10 years ago, the digital revolution came to the clinical trials industry, ushering in a host of new technologies for sites worldwide. While a few technologies were lauded, many sites found themselves overwhelmed by the sheer number of new offerings and frustrated by the numerous solutions proposed by sponsors that ultimately made trials more difficult. There are many steps that organizations can take to implement a site-first approach to ensure their tools aren’t missing the mark.

  6. Choosing The Right Survey Tool For Clinical Trials 3/28/2019

    Web-based survey tools can be extremely beneficial to pharmaceutical companies and CROs for reducing site selection cycle time as well as operational costs (not to mention the opportunity costs). But what sets site feasibility, and other clinical forms, apart from other nonclinical survey types?

  7. Expanded Access And Commercial Packaging Strategies For Orphan, Niche, And Low-Volume Drugs 7/20/2020

    Most commercial contract drug packagers do not provide consistent scheduling for low-volume drugs, which creates supply challenges. In fact, a drug packaging delay can create a market shortage that triggers serious health consequences for patients who rely on the drug. This issue can arise with niche and orphan drugs, as well as any other drugs packaged in small volumes. Conversely, a clinical supply partner can provide packaging as needed, plus handle distribution for expanded access and general commercial needs. This summary describes low-volume drugs, examines commercial packaging and supply challenges, and explores potential solutions.

  8. Best Practices For Site Communications During COVID-19 6/8/2020

    With so much new and updated information being shared on nearly a daily basis, it’s important to consider the most effective methods of organization and distribution. Here are some best practices we’ve compiled from working with sponsors and sites of all sizes and specialties during the COVID-19 pandemic.  

  9. Veeva Vault Payments Demo: Pay Sites Faster And More Accurately 1/27/2020

    Watch a 3-minute demo to see how Vault Payments can help you can improve speed, visibility, and accuracy to streamline payments to clinical research sites.

  10. COVID-19 Changed Everything: Now Contracts And Budgets Need To Catch Up 7/20/2020

    As we emerge from crisis-response mode we find ourselves in a period of transition and uncertainty. While much remains unresolved, we do know this: Sites and sponsors will be recalibrating everything, especially budgets for either new components of trials or changes to clinical trials. This article outlines five critical changes sites and sponsors should be considering to best plan for the future.